FiledIssuerIndustrySold
Mar 2026Pacegenix, Inc.Agents: LifeSci Capital, LLCBiotechnology$23M
Mar 2026Immunic, Inc.Biotechnology$200M
Jan 2026iBio, Inc.Biotechnology$26M
Nov 2025Galecto, Inc.Biotechnology$285M
Apr 2025DBV Technologies S.A.Pharmaceuticals$307M
Dec 2024Olema Pharmaceuticals, Inc.Pharmaceuticals$250M
Oct 2024OnKure Therapeutics, Inc.Pharmaceuticals$65M
Mar 2024Perspective Therapeutics, Inc.Agents: LifeSci Capital, LLCBiotechnology$87M
Mar 2024Crinetics Pharmaceuticals, Inc.Biotechnology$350M
Dec 2023Spyre Therapeutics, Inc.Biotechnology$180M
Dec 2023MedRhythms, Inc.Other Technology$19M
Nov 2023VYNE Therapeutics Inc.Biotechnology$88M
May 2023InspireMD, Inc.Other Health Care$42M
Apr 2023Provisio Medical, Inc.Agents: LifeSci CapitalOther Technology$4.5M
Nov 2022Provisio Medical, Inc.Agents: LifeSci CapitalOther Technology$11M
Nov 2021Sermonix Pharmaceuticals, Inc.Pharmaceuticals$40M
Aug 2021CytoImmune Therapeutics, Inc.Agents: Lifesci CapitalBiotechnology$37M
May 2021Allarity Therapeutics, Inc.Biotechnology$20M
Apr 2018Tracon Pharmaceuticals, Inc.Biotechnology$39M
Apr 2018Arix Bioscience plcOther Health Care$21M
Oct 2017Engage Therapeutics, Inc.Pharmaceuticals$24M
Mar 2017Gemphire Therapeutics Inc.Pharmaceuticals$13M
Dec 2015Erytech Pharma S.A.Biotechnology$4.0M
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.